Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Synergistic inhibitory effects of clopidogrel and rivaroxaban on platelet function and platelet-dependent thrombin generation in cats

Journal of Veterinary Internal Medicine(2023)10.1111/jvim.16727Source: DataRank Database

Synergistic inhibitory effects of clopidogrel and rivaroxaban on platelet function and platelet-dependent thrombin generation in cats is a research paper published in Journal of Veterinary Internal Medicine (2023). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 2.19)OA: goldTopics (52)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Ronald H. L. Li ORCID,Catherine J. Georges,Nghi Nguyen ORCID,Cheyenne K. Chen,Claire Stuhlmann

Live enrichment

PubMed:37208839 PMC:PMC10365033 OpenAlex:https://openalex.org/W4377142648

EveryCat Health Foundation

Grant: A21-2453-001

National Institutes of Health T35

Grant: OD010956

EveryCat Health Foundation

Grant: A21‐2453‐001

FWCI

2.19

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jvim.16727

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jvim.16727

publisherhttps://academic.oup.com/jvim/article-pdf/37/4/1390/66658548/jvim16727.pdf

journalhttps://doi.org/10.1111/jvim.16727

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37208839

Fields of Study

Cardiovascular Conditions and TreatmentsPlatelet Disorders and TreatmentsAntiplatelet Therapy and Cardiovascular DiseasesCatsAnimalsClopidogrelRivaroxabanPlatelet Aggregation InhibitorsThrombinTiclopidineCross-Over StudiesAspirinBlood PlateletsPlatelet AggregationAdenosine Diphosphate

MeSH Terms

RivaroxabanClopidogrelAdenosine DiphosphateAnimalsAspirinBlood PlateletsCatsPlatelet AggregationPlatelet Aggregation InhibitorsThrombinTiclopidineCross-Over Studies

Keywords

ClopidogrelMedicinePlateletRivaroxabanPlatelet activationThrombinAdenosine diphosphatePharmacologyEx vivoCATSInternal medicineAspirinAnesthesiaPlatelet aggregationChemistryWarfarinBiochemistryIn vitrohypertrophic cardiomyopathyThromboembolismCardiologycardiovascularFactor Xa inhibitorClopidogrel ResistanceSaddle Thrombus

Sustainable Development Goals

SDG 0: Good health and well-being